PATENT CLAIM ANALYSIS

Application Number: 15981915
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-09
Patent Classification: ["536", "029200"]

Abstract:
The present invention relates to pyrazolotriazolyl nucleoside analogues, oligonucleotide comprising them, and uses thereof. Further the invention relates to a method for reducing gene expression in a cell comprising transfecting the cell with such an oligonucleotide.

Claim (Index 6):
The oligonucleotide according to  claim 1 , wherein the oligonucleotide is an RNA oligonucleotide comprising one or more nucleoside or nucleotide analogues, each independently of the general formula II, wherein R 5  is \u2014OR 11 ; R 6  is \u2014OR 11 ; and R 11  each independently is (C 1 -C 8 )alkyl, (C 1 -C 8 )alkylene-OR 12 , (C 1 -C 8 )alkylene-SR 12 , or (C 1 -C 8 )alkylene-NR 12 R 13 , wherein R 12  and R 13  each independently is H or (C 1 -C 8 )alkyl, provided that at least one of R 12  and R 13  is not H.

Metadata:
- Claim Count in Document: 11.0
- Percentile: 93.0
- Lexical Diversity: 1.33333
- Patent Class: 536.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14403580', '09528110', '09565699', '14403581', '12192581']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6178178162071335
- 35 USC 102 Novelty (BERT): 0.5840183343553539
- Combined Prediction Score: 0.6144378680219555
- Mean Citation Score: 321.328756
- Max Citation Score: 520.20465
- Similarity Product: 433.9639718003154

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test